# SUTRO BIOPHARMA, INC.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/sutro-biopharma-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 28 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:52:58.534672+00:00 |
| Last reviewed | 2026-10-16T13:52:58.534672+00:00 |

## Identity

- Legal name: SUTRO BIOPHARMA, INC.
- Display name: SUTRO BIOPHARMA, INC.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T22:54:08.685536+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.842 |
| Directors | 9 |
| Committees | 7 |
| Governance events | 23 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Connie Matsui: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:5
- Daniel H. Petree: Director. Status: current. Independent: true. Since: 2009-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:6
- Heidi Hunter: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:7
- James Panek: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:8
- Jane Chung, R.Ph.: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:9
- Jon Wigginton, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:10
- Joseph M. Lobacki: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:11
- Michael Dybbs, Ph.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:12
- Sukhi Jagpal: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:13

## Committees

- Audit (audit). Chair: Sukhi Jagpal. Members: Sukhi Jagpal (chair, current); Heidi Hunter (member, current); Joseph M. Lobacki (member, current). committee_id=alpha:committee:sutro-biopharma-inc:audit
- Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Sukhi Jagpal (member, current). committee_id=alpha:committee:sutro-biopharma-inc:audit-chair
- Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Joseph M. Lobacki (member, current). committee_id=alpha:committee:sutro-biopharma-inc:audit-compensation-chair
- Compensation (compensation). Chair: Joseph M. Lobacki. Members: Joseph M. Lobacki (chair, current); Daniel H. Petree (member, current). committee_id=alpha:committee:sutro-biopharma-inc:compensation
- Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Daniel H. Petree (member, current). committee_id=alpha:committee:sutro-biopharma-inc:compensation-nominating-and-governance
- Nominating and Governance (nominating_governance). Chair: James Panek. Members: James Panek (chair, current); Connie Matsui (member, current); Daniel H. Petree (member, current). committee_id=alpha:committee:sutro-biopharma-inc:nominating-and-governance
- Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: James Panek (member, current). committee_id=alpha:committee:sutro-biopharma-inc:nominating-and-governance-chair

## Executive leadership

- David Pauling, J.D., M.A.: Chief Administrative Officer and General Counsel [GC]. Status: current. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:14
- Gregory Chow: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:15
- Hans-Peter Gerber, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:16
- Jane Chung, R.Ph.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:17

## Governance events

- GC_CHANGED: David Pauling, J.D., M.A. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:oa4ifc14v5asw
- CFO_CHANGED: Gregory Chow executive of SUTRO BIOPHARMA, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:1n736e2938knw
- EXECUTIVE_APPOINTED: Hans-Peter Gerber, Ph.D. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:bmiz62dpy1qo
- CEO_CHANGED: Jane Chung, R.Ph. executive of SUTRO BIOPHARMA, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:wechi5183hrtj
- DIRECTOR_APPOINTED: Jane Chung, R.Ph. seat on SUTRO BIOPHARMA, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:9z65z8kq7bq6
- DIRECTOR_APPOINTED: Sukhi Jagpal seat on SUTRO BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:mu79amvrd0wk
- COMMITTEE_CREATED: Audit · Chair committee of SUTRO BIOPHARMA, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:h25wse1899ito
- COMMITTEE_MEMBER_ADDED: Sukhi Jagpal member of Audit · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:157ik3utkgvwk
- DIRECTOR_APPOINTED: Heidi Hunter seat on SUTRO BIOPHARMA, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:lloscs1lggvbc
- COMMITTEE_MEMBER_ADDED: Heidi Hunter member of Audit, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:5slnrr1smjyjf
- DIRECTOR_APPOINTED: James Panek seat on SUTRO BIOPHARMA, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:1b28q74d4r5pe
- DIRECTOR_APPOINTED: Jon Wigginton, M.D. seat on SUTRO BIOPHARMA, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:2bmw094oremz
- COMMITTEE_CREATED: Nominating and Governance · Chair committee of SUTRO BIOPHARMA, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:1hniziw43x1ki
- COMMITTEE_MEMBER_ADDED: James Panek member of Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:147963w17n2n20
- DIRECTOR_APPOINTED: Connie Matsui seat on SUTRO BIOPHARMA, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:2nunmfybax2d
- COMMITTEE_MEMBER_ADDED: Connie Matsui member of Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:a1t2e29wqae4
- DIRECTOR_APPOINTED: Michael Dybbs, Ph.D. seat on SUTRO BIOPHARMA, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:1j64ycwdekmdu
- DIRECTOR_APPOINTED: Joseph M. Lobacki seat on SUTRO BIOPHARMA, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:u023cegjryh6
- COMMITTEE_CREATED: Audit; Compensation · Chair committee of SUTRO BIOPHARMA, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:reyxgeng5nmi
- COMMITTEE_MEMBER_ADDED: Joseph M. Lobacki member of Audit; Compensation · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:1hahkpr70c7f7
- DIRECTOR_APPOINTED: Daniel H. Petree seat on SUTRO BIOPHARMA, INC., effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:ohipyf1m3vzff
- COMMITTEE_CREATED: Compensation; Nominating and Governance committee of SUTRO BIOPHARMA, INC., effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:kf9jffggeg97
- COMMITTEE_MEMBER_ADDED: Daniel H. Petree member of Compensation; Nominating and Governance, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T13:52:58.534672+00:00. event_id=alpha:event:transition:4nt1wy1gwwolo

## Scoped resources

- `alpha://company/sutro-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record
- `alpha://company/sutro-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=identity
- `alpha://company/sutro-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=corporate-structure
- `alpha://company/sutro-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=board
- `alpha://company/sutro-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=committees
- `alpha://company/sutro-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=leadership
- `alpha://company/sutro-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=ownership
- `alpha://company/sutro-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=financials
- `alpha://company/sutro-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=capital-structure
- `alpha://company/sutro-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=compensation
- `alpha://company/sutro-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=governance
- `alpha://company/sutro-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=shareholder-governance
- `alpha://company/sutro-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=audit
- `alpha://company/sutro-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=legal
- `alpha://company/sutro-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=risk
- `alpha://company/sutro-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=cyber
- `alpha://company/sutro-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=ai-governance
- `alpha://company/sutro-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=agents
- `alpha://company/sutro-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=ecosystem
- `alpha://company/sutro-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=events
- `alpha://company/sutro-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=relationships
- `alpha://company/sutro-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=assessments
- `alpha://company/sutro-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:sukhi-jagpal","name":"Sukhi Jagpal"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:heidi-hunter","name":"Heidi Hunter"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:joseph-m-lobacki","name":"Joseph M. Lobacki"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:joseph-m-lobacki","name":"Joseph M. Lobacki"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:daniel-h-petree","name":"Daniel H. Petree"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:james-panek","name":"James Panek"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:connie-matsui","name":"Connie Matsui"},"source_id":"board_seats"}`
- Claim alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:daniel-h-petree","name":"Daniel H. Petree"},"source_id":"board_seats"}`

## Leadership

- Connie Matsui: Director, Nominating and Governance. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Daniel H. Petree: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:6. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Heidi Hunter: Director, Audit. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- James Panek: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Jane Chung, R.Ph.: Director. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Jon Wigginton, M.D.: Director. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Joseph M. Lobacki: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Michael Dybbs, Ph.D.: Director. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- Sukhi Jagpal: Director, Audit · Chair. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:13. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c.
- David Pauling, J.D., M.A.: Chief Administrative Officer and General Counsel. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:14. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f9351c27c73b7f20ab116420de4e2d1b1d77bb2de19b423ec8ae021c6b178acb.
- Gregory Chow: Chief Financial Officer. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:15. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6ea04634aea8dea013d7c472c9688342783111fa952a8595170074024532eae.
- Hans-Peter Gerber, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:16. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b613da76c1bb10cd26b4e05a9ad168fef31b5ffed602f8ab8035b9432fc8d0c5.
- Jane Chung, R.Ph.: Chief Executive Officer and Director. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:leadership_role:17. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:616a20af47b9e8467f1ddf67cc1271309fdb014ca06906870a7cd9b78a14d4c6.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Sukhi Jagpal; Members Sukhi Jagpal (Chair); Heidi Hunter; Joseph M. Lobacki. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Compensation: Chair Joseph M. Lobacki; Members Joseph M. Lobacki (Chair); Daniel H. Petree. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Nominating and Governance: Chair James Panek; Members James Panek (Chair); Connie Matsui; Daniel H. Petree. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- SUTRO BIOPHARMA, INC.. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7116d27f2a475e281870f387062dbcf8579e20f6c889778335a2125a3e364e86.

## Entity Status

- Public listing published. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7116d27f2a475e281870f387062dbcf8579e20f6c889778335a2125a3e364e86.

## Published Fact

- US. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7116d27f2a475e281870f387062dbcf8579e20f6c889778335a2125a3e364e86.

## Committee Appointment

- Sukhi Jagpal: chair, Audit. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Heidi Hunter: member, Audit. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Joseph M. Lobacki: member, Audit. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Joseph M. Lobacki: chair, Compensation. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Daniel H. Petree: member, Compensation. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- James Panek: chair, Nominating and Governance. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Connie Matsui: member, Nominating and Governance. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.
- Daniel H. Petree: member, Nominating and Governance. Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8.

## Security Listing

- STRO (NASDAQ). Claim: alpha:claim:company:e2ced279-8c85-4ffb-80aa-837bc3be31f5:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7116d27f2a475e281870f387062dbcf8579e20f6c889778335a2125a3e364e86.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:7116d27f2a475e281870f387062dbcf8579e20f6c889778335a2125a3e364e86: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sutro-biopharma-inc).
- alpha:projection-evidence:document:1277b3c96f186bc30b65acb4a167b432fcbc166bb046eec4794c3fb6622d625c: [SUTRO BIOPHARMA, INC. DEF 14A 2026-04-22](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).
- alpha:projection-evidence:document:f9351c27c73b7f20ab116420de4e2d1b1d77bb2de19b423ec8ae021c6b178acb: [STRO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).
- alpha:projection-evidence:document:d6ea04634aea8dea013d7c472c9688342783111fa952a8595170074024532eae: [STRO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).
- alpha:projection-evidence:document:b613da76c1bb10cd26b4e05a9ad168fef31b5ffed602f8ab8035b9432fc8d0c5: [STRO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).
- alpha:projection-evidence:document:616a20af47b9e8467f1ddf67cc1271309fdb014ca06906870a7cd9b78a14d4c6: [STRO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).
- alpha:projection-evidence:1a19fe6a30aa0b12075a4781f51ca96b0009dd7c59bb699f6e73a6d14fbd8fc8: [Audit](https://www.sec.gov/Archives/edgar/data/1382101/000119312526170354/stro-20260420.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/sutro-biopharma-inc)
- [Public Markdown](https://registry.alpha.ac/companies/sutro-biopharma-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/sutro-biopharma-inc?format=jsonld)
- MCP resource: `alpha://companies/sutro-biopharma-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-16T22:54:08.362203+00:00; recorded 2026-10-16T22:54:08.362203+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.